PMID- 1372291 OWN - NLM STAT- MEDLINE DCOM- 19920423 LR - 20210526 IS - 0019-9567 (Print) IS - 1098-5522 (Electronic) IS - 0019-9567 (Linking) VI - 60 IP - 4 DP - 1992 Apr TI - Lipooligosaccharides (LOS) of some Haemophilus species mimic human glycosphingolipids, and some LOS are sialylated. PG - 1322-8 AB - The lipooligosaccharides (LOS) of strains of Haemophilus ducreyi, Neisseria gonorrhoeae, Neisseria meningitidis, and Neisseria lactamica contain epitopes that are antigenically and structurally similar to carbohydrates present in human glycosphingolipids. LOS from strains of Haemophilus influenzae and H. influenzae biogroup aegyptius were tested for the binding of monoclonal antibodies (MAbs) that bind to human glycosphingolipids possessing Gal beta 1-4GlcNAc (MAb 3F11) and Gal alpha 1-4Gal beta 1-4Glc (MAb anti-Pk). In solid-phase radioimmunoassays, the LOS of 18 of 19 H. influenzae type b (Hib), 8 of 19 nontypeable H. influenzae, and 10 of 20 H. influenzae biogroup aegyptius strains bound MAb anti-Pk. The LOS of 13 of 19 Hib, 10 of 16 nontypeable H. influenzae, and 2 of 18 H. influenzae biogroup aegyptius strains bound MAb 3F11. Neuraminidase treatment of the strains increased the binding of MAb 3F11 by more than twofold in 47% of the H. influenzae strains, suggesting that sialic acid occluded the LOS structure recognized by MAb 3F11. The material released from neuraminidase-treated Hib LOS was confirmed to be sialic acid by high-performance anion-exchange chromatography. A recombinant plasmid containing genes involved in Hib LOS biosynthesis directed the expression (assembly) of the 3F11 epitope in Escherichia coli. These studies demonstrate that H. influenzae and H. influenzae biogroup aegyptius express at least two LOS epitopes that are similar to those present in human glycosphingolipids. Sialic acid was present on the LOS of some H. influenzae strains and prevented the binding of MAb 3F11 to its epitope. The oligosaccharide portion of sialylated LOS may also resemble sialylated oligosaccharides present in human glycosphingolipids (gangliosides). FAU - Mandrell, R E AU - Mandrell RE AD - Centre for Immunochemistry, University of California, San Francisco 94143. FAU - McLaughlin, R AU - McLaughlin R FAU - Aba Kwaik, Y AU - Aba Kwaik Y FAU - Lesse, A AU - Lesse A FAU - Yamasaki, R AU - Yamasaki R FAU - Gibson, B AU - Gibson B FAU - Spinola, S M AU - Spinola SM FAU - Apicella, M A AU - Apicella MA LA - eng GR - AI21620/AI/NIAID NIH HHS/United States GR - AI22998/AI/NIAID NIH HHS/United States GR - AI24616/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Infect Immun JT - Infection and immunity JID - 0246127 RN - 0 (Antibodies, Monoclonal) RN - 0 (Antigens, Bacterial) RN - 0 (Epitopes) RN - 0 (Glycosphingolipids) RN - 0 (Lipopolysaccharides) RN - 0 (Sialic Acids) RN - 0 (lipid-linked oligosaccharides) RN - EC 3.2.1.18 (Neuraminidase) RN - GZP2782OP0 (N-Acetylneuraminic Acid) SB - IM MH - Antibodies, Monoclonal MH - Antigens, Bacterial/immunology MH - Blotting, Western MH - Carbohydrate Sequence MH - Chromatography, Ion Exchange MH - Epitopes MH - Glycosphingolipids/*immunology MH - Haemophilus influenzae MH - Humans MH - Lipopolysaccharides/*immunology MH - Molecular Sequence Data MH - N-Acetylneuraminic Acid MH - Neuraminidase/pharmacology MH - Plasmids MH - Sialic Acids/*analysis PMC - PMC256999 EDAT- 1992/04/01 00:00 MHDA- 1992/04/01 00:01 PMCR- 1992/04/01 CRDT- 1992/04/01 00:00 PHST- 1992/04/01 00:00 [pubmed] PHST- 1992/04/01 00:01 [medline] PHST- 1992/04/01 00:00 [entrez] PHST- 1992/04/01 00:00 [pmc-release] AID - 10.1128/iai.60.4.1322-1328.1992 [doi] PST - ppublish SO - Infect Immun. 1992 Apr;60(4):1322-8. doi: 10.1128/iai.60.4.1322-1328.1992.